Relmada Therapeutics RLMD
NASDAQ RLMD
$3.30 +0.09 (+2.80%)
As of: Oct 22, 2026 · 10:45 AM EDT

Relmada Therapeutics (RLMD) EBITDA Margin (2015 - 2021)

Updated

Analysis

Relmada Therapeutics (RLMD) EBITDA Margin (2015 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,162.99 Bn 1,131.58 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 633.71 Bn 552.23 Bn 17.26 Bn 35.95%
3 AbbVie 502.40 Bn 475.51 Bn 12.70 Bn 49.01%
4 Merck 376.48 Bn 330.86 Bn 12.21 Bn 6.02%
5 Novartis Ag 303.61 Bn 267.60 Bn 11.24 Bn -
6 Astrazeneca 267.02 Bn 240.70 Bn 12.86 Bn 33.11%
7 Amgen 240.85 Bn 196.25 Bn 7.24 Bn 46.01%
8 Gilead Sciences 193.39 Bn 167.58 Bn 6.22 Bn -124.26%
9 Pfizer 172.14 Bn 118.78 Bn 10.94 Bn 39.16%
10 Relmada Therapeutics 370.84 Mn -187.75 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -95,047.20%
Dec 31, 2020 -9,329.30%
Sep 30, 2020 -5,307.09%
Sep 30, 2019 -9,775.06%
Mar 31, 2019 -16,945.41%
Sep 30, 2017 -176.91%
Jun 30, 2017 -856,614.08%
Mar 31, 2017 -477,734.46%
Jun 30, 2016 -162,506.96%
Mar 31, 2016 -349,552.44%
Jun 30, 2015 -925,297.76%
API Access

Relmada Therapeutics EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RLMD&period=max&api_key=YOUR_API_KEY